明達醫

-1.60 (-2.07%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

75.8029成交張數13.00本益比1.86股價淨值比3.83%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	14	10	23.9%	2.02	40.51	14.9%	11.5%	-0.2	-0.5
2026Q1	13	10	25.8%	1.75	38.85	15.1%	11.3%	0.7	-0.1
2025Q4	13	10	20.6%	2.45	40.40	14.9%	11.8%	0.5	0.3
2025Q3	12	10	16.0%	3.05	38.92	14.7%	12.2%	0.7	0.0
2025Q2	12	10	21.6%	2.56	37.56	15.1%	11.8%	-0.2	-0.8
2025Q1	12	9	23.7%	2.54	36.08	14.7%	11.5%	0.3	0.1
2024Q4	12	9	20.8%	3.00	36.86	14.2%	11.2%	0.6	-0.3
2024Q3	11	9	17.5%	3.90	35.69	13.3%	10.8%	0.8	0.8
2024Q2	11	9	21.4%	3.15	34.37	12.8%	9.7%	0.1	-0.4
2024Q1	11	9	19.5%	3.69	34.90	12.7%	10.1%	0.1	0.1
2023Q4	11	9	20.5%	3.46	33.66	12.7%	9.9%	0.7	0.7
2023Q3	10	8	20.0%	3.54	32.93	14.5%	11.2%	0.6	0.6
2023Q2	11	8	26.2%	2.62	32.14	17.0%	12.5%	0.4	0.4
2023Q1	10	8	22.3%	3.10	33.07	15.6%	12.1%	-0.1	-0.1
2022Q4	10	8	23.4%	2.90	31.95	15.4%	11.8%	0.1	0.1
2022Q3	10	8	25.5%	2.62	31.18	14.9%	11.4%	0.4	0.4
2022Q2	10	7	27.1%	2.40	29.71	12.5%	9.5%	0.2	0.2
2022Q1	10	7	22.1%	2.97	30.52	11.2%	8.7%	-0.2	-0.2
2021Q4	9	7	23.4%	2.75	29.61	11.1%	8.5%	0.8	0.7
2021Q3	9	7	20.9%	2.69	28.64	10.3%	8.3%	0.4	0.4
2021Q2	9	7	20.7%	2.73	29.32	11.0%	8.5%	-0.1	-3.5
2021Q1	9	7	22.3%	4.16	28.60	9.1%	7.2%	-0.5	-0.5
2020Q4	9	7	23.9%	4.16	27.81	–	–	0.8	0.6
2020Q3	8	7	18.9%	5.59	27.14	–	–	0.1	0.1
2020Q2	9	7	24.3%	4.59	27.09	–	–	-0.2	-0.2
2020Q1	9	7	18.4%	6.63	29.39	–	–	0.1	0.1